Latest Breaking News On - Hale animal health - Page 1 : vimarsana.com

Business.Scoop » Punakaiki Sets A Record For Investor Participation On Catalist Marketplace

Business Scoop provides news and views on Business and Markets from New Zealand

The owners who are sourcing black market CBD oil for their pets

Helius celebrates female leadership in cannabis sector

Business Scoop » Helius Celebrates Female Leadership In Cannabis Sector

New Zealand Vets Invited to Attend Event About CBD Use For Pets

Vets Invited To 'Cannabis For Pets' Education Event

Hale - Ginger cat with Best Life. Leading the development of some of the world’s first clinically trialled and registered cannabis medicines for pets, Hale Animal Health is inviting the country’s vets to take a tour of New Zealand’s largest ...

auckland.scoop.co.nz » Vets Invited To 'Cannabis For Pets' Education Event

Press Release – Hale Animal Health Hale – Ginger cat with Best Life. Leading the development of some of the world’s first clinically trialled and registered cannabis medicines for pets, Hale Animal Health is inviting the country’s vets to take a tour of New Zealand’s largest medicinal cannabis facility. Part-owned by medicinal cannabis company, Helius Therapeutics, Hale Animal Health is set to host veterinarians at its joint headquarters. Those in attendance will hear more about the future of cannabidiol-based (CBD) products for New Zealand’s pets as well as first-hand international insights. An update will be provided on the extensive R&D work now underway in the quest for Hale’s CBD veterinary-prescribed medicines to achieve approval by the country’s regulator, ACVM (Agricultural Compounds and Veterinary Medicines).

Demand for pet DNA testing increasing - could medicinal cannabis for animals also catch on?

Helius appoints chief commercial officer

Mark Morrison has been a consultant with the firm for the past six months. Tue, 18 May 2021 Mark Morrison Mark Morrison has been appointed chief commercial officer at New Zealand-licenced medicinal cannabis company Helius Therapeutics. For six months prior to the appointment, he was a consultant at Helius where he developed the company’s commercial strategy. The announcement of CCO completes the executive leadership team at the Auckland Helius headquarters. With significant experience in Australia, the US and New Zealand, Morrison has worked in the pharmaceutical, animal health, and FMCG industries for more than 25 years. He has held senior global marketing, strategic planning, new product and business development positions, and has consulted in the medicinal cannabis sector since 2018.

Helius appoints chief commercial officer